Product NDC: | 14783-045 |
Proprietary Name: | LBel Paris |
Non Proprietary Name: | Octinoxate, Octisalate, and Oxybenzone |
Active Ingredient(s): | .375; .2; .2 g/5g; g/5g; g/5g & nbsp; Octinoxate, Octisalate, and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14783-045 |
Labeler Name: | Ventura International LTD |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100815 |
Package NDC: | 14783-045-51 |
Package Description: | 1 JAR in 1 BOX (14783-045-51) > 5 g in 1 JAR (14783-045-52) |
NDC Code | 14783-045-51 |
Proprietary Name | LBel Paris |
Package Description | 1 JAR in 1 BOX (14783-045-51) > 5 g in 1 JAR (14783-045-52) |
Product NDC | 14783-045 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate, Octisalate, and Oxybenzone |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100815 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Ventura International LTD |
Substance Name | OCTINOXATE; OCTISALATE; OXYBENZONE |
Strength Number | .375; .2; .2 |
Strength Unit | g/5g; g/5g; g/5g |
Pharmaceutical Classes |